Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Segment CMR

K-Number: K163076 · 2017-04-05

ApplicantMedviso AB
Decision Date2017-04-05
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Segment CMR is a medical device manufactured by Medviso AB. It received FDA 510(k) clearance on 2017-04-05 under approval number K163076. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Segment CMR?

Segment CMR is a medical device that received FDA 510(k) clearance on 2017-04-05. It is manufactured by Medviso AB. The 510(k) number is K163076.

When was Segment CMR approved by the FDA?

Segment CMR received FDA 510(k) clearance on 2017-04-05, under approval number K163076.

What company makes Segment CMR?

Segment CMR is manufactured by Medviso AB.

What is the FDA product code for Segment CMR?

The FDA product code for Segment CMR is LLZ.

Other Devices by Medviso AB

K211966Segment 3DPrint

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑